A pathway map of prolactin signaling

Journal of Cell Communication and Signaling

Volumn 6, Issue 3, 2012, Pages 169-173

  Radhakrishnan, Aneesha ^a,b   Raju, Rajesh ^a,c   Tuladhar, Nirvana ^d   Subbannayya, Tejaswini ^a,e   Thomas, Joji Kurian ^a,e   Goel, Renu ^a,c   Telikicherla, Deepthi ^a,c   Palapetta, Shyam Mohan ^a,b   Rahiman, B Abdul ^c   Venkatesh, Desai Dattatraya ^d   Urmila, Kulkarni Kale ^d   Harsha, H C ^a   Mathur, Premendu Prakash ^b   Prasad, T S Keshava ^a,b,e,f   Pandey, Akhilesh ^g   Shemanko, Carrie ^h   Chatterjee, Aditi ^a  

^a Institute of Bioinformatics   (India)

^b PONDICHERRY UNIVERSITY   (India)

^c KUVEMPU UNIVERSITY   (India)

^d UNIVERSITY OF PUNE   (India)

^e AMRITA UNIVERSITY   (India)

^f MANIPAL UNIVERSITY   (India)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

JANUS KINASE 2; PROLACTIN; PROLACTIN RECEPTOR; RAC PROTEIN; STAT PROTEIN;

ARTICLE; CATALYSIS; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 84866361456     PISSN: 18739601     EISSN: 1873961X     Source Type: Journal    
DOI: 10.1007/s12079-012-0168-0     Document Type: Article

References (32)

1. Ben-Jonathan N, Hugo ER, Brandebourg TD, LaPensee CR (2006) Focus on prolactin as a metabolic hormone. Trends Endocrinol Metab 17:110-116
2. Binart N, Ormandy CJ, Kelly PA (2000) Mammary gland development and the prolactin receptor. Adv Exp Med Biol 480:85-92
3. Bishop JD, Nien WL, Dauphinee SM, Too CK (2006) Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. J Endocrinol 190:307-312
4. Bouilly J, Sonigo C, Auffret J, Gibori G, Binart N (2011) Prolactin signaling mechanisms in ovary. Mol Cell Endocrinol
5. Clevenger CV, Furth PA, Hankinson SE, Schuler LA (2003) The role of prolactin in mammary carcinoma. Endocr Rev 24:1-27
6. Clevenger CV, Gadd SL, Zheng J (2009) New mechanisms for PRLr action in breast cancer. Trends Endocrinol Metab 20:223-229
7. Corbacho AM, Nava G, Eiserich JP, Noris G, Macotela Y, Struman I, Martinez De La Escalera G, Freeman BA, Clapp C (2000) Proteolytic cleavage confers nitric oxide synthase inducing activity upon prolactin. J Biol Chem 275:13183-13186
8. Corbacho AM, Martinez De La Escalera G, Clapp C (2002) Roles of prolactin and related members of the prolactin/growth hormone/placental lactogen family in angiogenesis. J Endocrinol 173:219- 238
9. Das R, Vonderhaar BK (1996) Involvement of SHC, GRB2, SOS and RAS in prolactin signal transduction in mammary epithelial cells. Oncogene 13:1139-1145
10. DaSilva L, Rui H, Erwin RA, Howard OM, Kirken RA, Malabarba MG, Hackett RH, Larner AC, Farrar WL (1996) Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580. Mol Cell Endocrinol 117:131-140
11. Demir E, Cary MP, Paley S, Fukuda K, Lemer C, Vastrik I, Wu G, D'Eustachio P, Schaefer C et al (2010) The BioPAX community standard for pathway data sharing. Nat Biotechnol 28:935-942
12. Dominguez-Caceres MA, Garcia-Martinez JM, Calcabrini A, Gonzalez L, Porque PG, Leon J, Martin-Perez J (2004) Prolactin induces c-Myc expression and cell survival through activation of Src/Akt pathway in lymphoid cells. Oncogene 23:7378-7390
13. Freeman ME, Kanyicska B, Lerant A, Nagy G (2000) Prolactin: structure, function, and regulation of secretion. Physiol Rev 80: 1523-1631
14. Goel R, Muthusamy B, Pandey A, Prasad TS (2011) Human protein reference database and human proteinpedia as discovery resources for molecular biotechnology. Mol Biotechnol 48:87-95
15. Goel R, Raju R, Maharudraiah J, Kumar GSS, Ghosh K, Kumar A, Lashmi PT, Sharma J, Sharma R et al (2012) A signaling network of thyroid-stimulating hormone. J Proteomics Bioinformatics
16. Goffin V, Bogorad RL, Touraine P (2010) Identification of gain-offunction variants of the human prolactin receptor.Methods Enzymol 484:329-355
17. Hermjakob H, Montecchi-Palazzi L, Bader G,Wojcik J, Salwinski L, Ceol A, Moore S, Orchard S, Sarkans U et al (2004) The HUPO PSI's molecular interaction format-a community standard for the representation of protein interaction data. Nat Biotechnol 22:177-183
18. Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D et al (2003) The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 19:524-531
19. Kandasamy K, Keerthikumar S, Raju R, Keshava Prasad TS, Ramachandra YL, Mohan S, Pandey A (2009) PathBuilder-open source software for annotating and developing pathway resources. Bioinformatics 25:2860-2862
20. Kandasamy K, Mohan SS, Raju R, Keerthikumar S, Kumar GS, Venugopal AK, Telikicherla D, Navarro JD, Mathivanan S et al (2010) NetPath: a public resource of curated signal transduction pathways. Genome Biol 11:R3
21. Martini JF, Piot C, Humeau LM, Struman I, Martial JA, Weiner RI (2000) The antiangiogenic factor 16K PRL induces programmed cell death in endothelial cells by caspase activation.Mol Endocrinol 14:1536-1549
22. Nanjappa V, Raju R, Muthusamy B, Sharma J, Thomas JK, Nidhina PAH, Harsha HC, Pandey A, Anilkumar G et al (2011) A comprehensive curated reaction map of leptin signaling pathway. J Proteomics Bioinformatics 4:184-189
23. Pezet A, Buteau H, Kelly PA, Edery M (1997) The last proline of Box 1 is essential for association with JAK2 and functional activation of the prolactin receptor. Mol Cell Endocrinol 129:199-208
24. Piazza TM, Lu JC, Carver KC, Schuler LA (2009) SRC family kinases accelerate prolactin receptor internalization, modulating trafficking and signaling in breast cancer cells. Mol Endocrinol 23:202-212
25. Raju R, Balakrishnan L, Nanjappa V, Bhattacharjee M, Getnet D, Muthusamy B, Kurian Thomas J, Sharma J, Rahiman BA et al. (2011a) A comprehensive manually curated reaction map of RANKL/RANK-signaling pathway. Database (Oxford) 2011:
26. Raju R, Nanjappa V, Balakrishnan L, Radhakrishnan A, Thomas JK, Sharma J, Tian M, Palapetta SM, Subbannayya T et al (2011b) NetSlim: high-confidence curated signalingmaps.Database (Oxford) 2011
27. Rider L, Shatrova A, Feener EP, Webb L, Diakonova M (2007) JAK2 tyrosine kinase phosphorylates PAK1 and regulates PAK1 activity and functions. J Biol Chem 282:30985-30996
28. Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V, Weiner RI, Martial JA (1999) Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA 96:1246- 1251
29. Telikicherla D, Ambekar A, Palapetta SM, Dwivedi SB, Raju R, Sharma J, Prasad TS, Ramachandra YL, Mohan SS et al (2011) A comprehensive curated resource for Follicle Stimulating Hormone signaling. BMC Res Notes 4:408
30. Utama FE, Tran TH, Ryder A, LeBaron MJ, Parlow AF, Rui H (2009) Insensitivity of human prolactin receptors to nonhuman prolactins: relevance for experimental modeling of prolactin receptorexpressing human cells. Endocrinology 150:1782-1790
31. van Iersel MP, Kelder T, Pico AR, Hanspers K, Coort S, Conklin BR, Evelo C (2008) Presenting and exploring biological pathways with PathVisio. BMC Bioinforma 9:399
32. Yamauchi T, Kaburagi Y, Ueki K, Tsuji Y, Stark GR, Kerr IM, Tsushima T, Akanuma Y, Komuro I et al (1998) Growth hormone and prolactin stimulate tyrosine phosphorylation of insulin receptor substrate- 1, -2, and -3, their association with p85 phosphatidylinositol 3- kinase (PI3-kinase), and concomitantly PI3-kinase activation via JAK2 kinase. J Biol Chem 273:15719-15726